AcuraStem

AcuraStem, Inc. is a privately held, patient-based biotechnology company headquartered in Monrovia, California, developing therapeutics for neurodegenerative diseases including sporadic ALS (amyotrophic lateral sclerosis) and frontotemporal dementia (FTD). The company's proprietary iNeuroRx drug-discovery platform builds disease models from induced pluripotent stem cells (iPSC) taken from individual patients, in place of animal models, and pairs them with machine-learning analysis to identify and validate targets. Its lead antisense oligonucleotide candidate, AS-241 (PIKFYVE), is advancing toward first-in-human testing with California Institute for Regenerative Medicine (CIRM) grant support. AcuraStem is a therapeutics developer rather than a software vendor: it publishes no public API, developer portal, SDK, or machine-readable contract of any kind. This profile records that absence with the probe evidence behind it.

AcuraStem is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Life Sciences, and Drug Discovery.

AcuraStem’s developer surface includes engineering blog and 9 more developer resources.

7.4/100 minimal Agent 0/100 human only Full breakdown ↓
scored 2026-09-06 · rubric v0.19.0
0 APIs
CompanyBiotechnologyTherapeuticsLife SciencesDrug DiscoveryNeuroscienceNeurodegenerative DiseaseALSStem CellsMachine LearningPrivate Company

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-06 · rubric v0.19.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/acurastem: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Acurastem Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Access & Security 1

Authentication, authorization, and security posture

Commercial 1

Pricing, plans, and the legal terms of use

Company 6

The organization behind the API

Other 1

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: acurastem
name: AcuraStem
description: 'AcuraStem, Inc. is a privately held, patient-based biotechnology company headquartered in Monrovia, California,
  developing therapeutics for neurodegenerative diseases including sporadic ALS (amyotrophic lateral sclerosis) and frontotemporal
  dementia (FTD). The company''s proprietary iNeuroRx drug-discovery platform builds disease models from induced pluripotent
  stem cells (iPSC) taken from individual patients, in place of animal models, and pairs them with machine-learning analysis
  to identify and validate targets. Its lead antisense oligonucleotide candidate, AS-241 (PIKFYVE), is advancing toward first-in-human
  testing with California Institute for Regenerative Medicine (CIRM) grant support. AcuraStem is a therapeutics developer
  rather than a software vendor: it publishes no public API, developer portal, SDK, or machine-readable contract of any kind.
  This profile records that absence with the probe evidence behind it.'
url: https://raw.githubusercontent.com/api-evangelist/acurastem/refs/heads/main/apis.yml
image: https://acurastem.com/application/files/7516/7235/4056/acs_logo_notag.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-06'
modified: '2026-09-06'
tags:
- Company
- Biotechnology
- Therapeutics
- Life Sciences
- Drug Discovery
- Neuroscience
- Neurodegenerative Disease
- ALS
- Stem Cells
- Machine Learning
- Private Company
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/acurastem-domain-security.yml
- type: LLMsTxt
  url: llms/acurastem-llms.txt
- type: Website
  url: https://acurastem.com/
- type: About
  url: https://acurastem.com/about-us
- type: Blog
  url: https://acurastem.com/blog
- type: Newsroom
  url: https://acurastem.com/media
- type: Careers
  url: https://acurastem.com/careers
- type: PrivacyPolicy
  url: https://acurastem.com/privacy-policy
- type: LinkedIn
  url: https://www.linkedin.com/company/12903559/
- type: X
  url: https://x.com/acurastem
x-enrichment:
  date: '2026-09-06'
  status: minimal
  artifacts_added: 3
  pass: local-v3
x-coverage:
  state: none
  reason: not-a-software-company
  detail: AcuraStem is a preclinical ALS/FTD therapeutics developer whose entire public web presence is a six-page Concrete
    CMS 9.5.2 marketing site (about, science, therapeutics, media, careers) with no developer, API, or data-access section,
    no API subdomain resolving in DNS, and an empty GitHub organization with zero public repositories.
  evidence:
  - url: https://acurastem.com/
    status: 200
  - url: https://acurastem.com/openapi.json
    status: 404
  - url: https://acurastem.com/.well-known/api-catalog
    status: 404
  - url: https://acurastem.com/llms.txt
    status: 404
  - url: https://acurastem.com/sitemap.xml
    status: 200
  - url: https://api.github.com/orgs/acurastem
    status: 200
  checked: '2026-09-06'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/acurastem"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/acurastem/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/acurastem/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

A second provider on the same verified email joins the account you already have.